Real-World Evidence in Oncology: Opportunities and Limitations

Maïo et al. (Tue,) studied this question.

www.synapsesocial.com/papers/69d78dca5f9a1dad534907e7 — DOI: https://doi.org/10.1634/theoncologist.2019-0647

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Systematic Review of Adverse Events Reporting in Clinical Trials Leading to Approval of Targeted Therapy and Immunotherapy· 2019 · 13 citations
2. Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer· 2012 · 3,753 citations
3. Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study· 2018 · 1,180 citations
4. Building a Rapid Learning Health Care System for Oncology: The Regulatory Framework of CancerLinQ· 2014 · 108 citations
5. Real-World or Controlled Clinical Trial Data in Real-World Practice· 2018 · 1 citations